Congress – Policy & Medicine

James Comer Calls on PBM Executives to Revise Testimony Presented to Congress

Protecting Patients from Deceptive Drug Ads Online Act Introduced

Congress Sends Letter to FDA Regarding Clinical Trials in China

CMMI Under Fire?

House Energy and Commerce Subcommittee Holds Hearing on 340B Drug Pricing Program and Legislation

House Energy and Commerce Committee Unanimously Passes Bill for Patient Access to Medications

The Improving Seniors’ Timely Access to Care Act Reintroduced in Congress

The Change Healthcare Cyberattack and Its Impact on the U.S. Healthcare System

Senators Urge FDA to Crack Down on Social Media Prescription Drug Promotion

Bipartisan Group of Attorneys General Send Letter to Congress, Urging PBM Reform